Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Arbutus Biopharma (NASDAQ:ABUS) through any online brokerage.
Other companies in Arbutus Biopharma’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), ARS Pharmaceuticals Inc (NASDAQ:SPRY), CytomX Therapeutics Inc (NASDAQ:CTMX), Gyre Therapeutics Inc (NASDAQ:GYRE) and CareDx Inc (NASDAQ:CDNA).
Arbutus Biopharma has a consensus price target of $5.50.
The stock price for Arbutus Biopharma (NASDAQ: ABUS) is $4.67 last updated April 16, 2026 at 7:19 PM EDT.
There are no upcoming dividends for Arbutus Biopharma.
Arbutus Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for Arbutus Biopharma.
Arbutus Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.